Comparative Bioavailability of Tizanidine in Three Dosage Forms (6-MG Delayed-Release Tablets, Sirdalud Preparation, and 2-MG Tablets)
Crossref DOI link: https://doi.org/10.1007/s11094-016-1458-2
Published Online: 2016-10-08
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kukes, V. G.
Reikhart, D. V.
Artnautov, V. S.
Torshina, E. V.
Kapashin, A. V.
Belostotskii, A. V.
Text and Data Mining valid from 2016-09-01
Version of Record valid from 2016-09-01
Article History
Received: 13 May 2016
First Online: 8 October 2016